Role of endothelin-1 in renal regulation of acid-base equilibrium in acidotic humans

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 7, 2012, Pages

  Pallini, Alexandra ^a   Hulter, Henry N ^b   Muser, Jurgen ^a   Krapf, Reto ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bosentan; Endothelin 1; Metabolic acidosis; Mineralocorticoids; Renal acidification

Indexed keywords

BICARBONATE; BOSENTAN; ENDOTHELIN 1; MINERALOCORTICOID;

ACID BASE BALANCE; ACIDIFICATION; ADULT; AMMONIA FORMATION; ARTICLE; BICARBONATE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; METABOLIC ACIDOSIS; NORMAL HUMAN; PRIORITY JOURNAL; SODIUM INTAKE; SODIUM RESTRICTION; URINARY EXCRETION; VOLUNTEER;

EID: 84867114046     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00309.2012     Document Type: Article

References (37)

1. Ahn D, Ge Y, Stricklett PK, Gill P, Taylor D, Hughes AK, Yanagisawa M, Miller L, Nelson RD, Kohan DE. Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention. J Clin Invest 114: 504-511, 2004.
2. Cogan MG, Carneiro AV, Tatsuno J, Colman J, Krapf R, Morris RC Jr, Sebastian A. Normal diet NaCl variation can affect the renal set-point for plasma H-(HCO3) maintenance. J Am Soc Nephrol 1: 193-199, 1990.
3. DeBrito I, Varagunam M, Raftery MJ, Yaqoop MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 20: 2075-2084, 2009.
4. De Sousa RC, Harrington JT, Ricanati ES, Shelkrot JW, Schwartz WB. Renal regulation of acid-base equilibrium during chronic administration of mineral acid. J Clin Invest 53: 465-476, 1974.
5. 2, pH, and lactate form arterialized venous blood. J Appl Physiol 32: 134-137, 1972.
6. Francis BN, Abassi Z, Heyman S, Winaver J, Hoffman A. Differential regulation of ETA and ETB in the renal tissue of rats with compensated and decompensated heart failure. J Cardiovasc Pharmacol 44: S362-S365, 2004.
7. Ge Y, Ahn D, Stricklett PK, Hughes AK, Yanagisawa M, Verbalis JG, Kohan DE. Collecting duct-specific knockout of endothelin-1 alters vasopressin regulation of urine osmolality. Am J Physiol Renal Physiol 288: F912-F920, 2005.
8. Goraya N, Simoni J, Ja C, Wesson DE. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int 81: 86-93, 2012.
9. Harrington JT, Hulter HN, Cohen JJ, Madias NE. Mineralocorticoidstimulated renal acidification: the critical role of dietary sodium. Kidney Int 30: 43-48, 1986.
10. Khanna A, Simoni J, Hacker C, Duran MJ, Wesson DE. Increased endothelin activity mediates augmented distal nephron acidification induced by dietary protein. J Am Soc Nephrol 15: 2266-2275, 2004.
11. Khanna A, Simoni J, Hacker C, Duran MJ, Wesson DE. Increased endothelin activity mediates augmented distal nephron acidification induced by dietary protein. Trans Am Clin Climatol Assoc 116: 239-256, 2005.
12. Khanna A, Simoni J, Wesson DE. Endothelin-induced increases in aldosterone activity mediates augmented distal nephron acidification as a result of dietary protein. J Am Soc Nephrol 16: 1929-1935, 2005.
13. Kohan DE, Rossi NF, Inscho EW, Pollock DM. Regulation of blood pressure, and salt homeostasis by endothelin. Phys Rev 91: 1-77, 2011.
14. Krapf R, Beeler I, Hertner D, Hulter HN. Chronic respiratory alkalosis. The effect of sustained hyperventilation on renal regulation of acid-base equilibrium. N Engl J Med 324: 1394-1401, 1991.
15. Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. N Engl J Med 338: 784-790, 1998.
16. Kurtz TW, Morris RC Jr. Dietary chloride as a determinant of "sodiumdependent" hypertension. Science 222: 1139-1141, 1983.
17. Laghamani K, Preisig P, Alpern RJ. The role endothelin in proximal tubule proton secretion, and the adaptation to a chronic metabolic acidosis. J Nephrol 15: S75-S87, 2002.
18. Laghamani K, Preisig PA, Moe OW, Yanagisawa M, Alpern RJ. Endothelin-1/endothelin-B receptor-mediated increases in NHE3 activity in chronic metabolic acidosis. J Clin Invest 107: 1563-1569, 2011.
19. Lazich I, Bakris GL. Endothelin Antagonism in patients with resistant hypertension, and hypertension nephropathy. In: Endothelin in Renal Physiology and Disease (Contributions to Nephrology), edited by Barton M, Kohan DE. Basel, Switzerland: Karger, 2011, p. 223-234.
20. Mahajan A, Simoni J, Sheather SJ, Broglio KR, Rajab MH, Wesson DE. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney Int 78: 303-309, 2010.
21. Mann JFE, Green D, Jamerson K, Ruilope LM, Kuranoff SJ, Littke T, Vibertis G. Avosentan for overt diabetic nephropathy. J Am Soc Nephrol 21: 527-535, 2010.
22. Mazzochi G, Malendowicz LK, Nussdorfer GG. Endothelin-1 acutely stimulates the secretory activity of rat zona glomerulosa cells. Peptides 11: 763-765, 1990.
23. Phisitikul S, Hacker C, Simoni J, Tran RM, Wesson DE. Dietary protein causes a decline in the glomerular filtration rate of the remnant kidney mediated by metabolic acidosis and endothelin receptors. Kidney Int 73: 192-199, 2008.
24. Phisitikul S, Khanna A, Simoni J, Broglio K, Sheather S, Rajab MH, Wesson DE. Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR. Kidney Int 77: 617-623, 2010.
25. Prabhakar SS. Regulatory and functional interaction of vasoactive factors in the kidney and extracellular pH. Kidney Int 66: 1742-1654, 2004.
26. Schwartz WB, Bank N, Cutler RWP. The influence of urinary ionic strength on the phosphate pK2= and the determination of titratable acid. J Clin Invest 38: 247-256, 1959.
27. Terada Y, Tomita K, Nonoguchi H, Marumo F. Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay. J Clin Invest 90: 107-112, 1992.
28. Toto RD, Hulter HN, Mackie S, Sebastian A. Renal tubular acidosis induced by dietary chloride. Kidney Int 25: 26-32, 1984.
29. Ulrich S, Speich R, Domenighetti D, Geiser T, Aubert JD, Rochat T, Huber L, Treder U, Fischler M. Bosentan therapy for chronic thromboembolic pulmonary hypertension. Swiss Med Wkly 137: 573-580, 2007.
30. van Giersbergen PL, Treiber A, Clozel M, Bodin F, Dingemanse J. In vivo and in vitro studies exploring the pharmacokinetic interaction between bosentan, a dual endothelin receptor antagonist, and glyburide. Clin Pharmacol Ther 71: 253-262, 2002.
31. Wesson DE, Dolson GM. Endothelin-1 increases rat distal tubule acidification in vivo. Am J Physiol Renal Physiol 273: F586-F594, 1997.
32. Wesson DE. Endogenous endothelins mediate increased distal tubule acidification induced by dietary acid in rats. J Clin Invest 99: 2203-2211, 1997.
33. Wesson DE, Nathan T, Rose T, Simoni J, Tran RM. Dietary protein induces endothelin-mediated kidney injury through enhanced intrinsic acid production. Kidney Int 71: 210-217, 2007.
34. Wesson DE, Simoni J, Prabhakar S. Endothelin-induced increased nitric oxide mediates augmented distal nephron acidification as a result of dietary protein. J Am Soc Nephrol 17: 406-413, 2006.
35. Wesson DE, Simoni J. Increased Tissue acid mediates a progressive decline in the glomerular filtration rate of animals with reduced nephron mass. Kidney Int 75: 929-935, 2009.
36. Wu-Wong JR, Dixon DB, Chiou WJ, Opgenorth TJ. Endothelin receptor antagonists: effect of serum albumin on potency and comparison of pharmacological characteristics. J Pharmacol Exp Ther 281: 791-798, 1997.
37. Wu-Wong JR, Chiou WJ, Hoffman DJ, Winn M, von Geldern TW, Opgenorth TJ. Endothelins and endothelin receptor antagonists: binding to plasma proteins. Life Sci 58: 1839-1847, 1996.